321 related articles for article (PubMed ID: 27707591)
1. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review.
Brunssen A; Waldmann A; Eisemann N; Katalinic A
J Am Acad Dermatol; 2017 Jan; 76(1):129-139.e10. PubMed ID: 27707591
[TBL] [Abstract][Full Text] [Related]
2. Screening for Skin Cancer in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Wernli KJ; Henrikson NB; Morrison CC; Nguyen M; Pocobelli G; Blasi PR
JAMA; 2016 Jul; 316(4):436-47. PubMed ID: 27458949
[TBL] [Abstract][Full Text] [Related]
3. Melanoma screening: A plan for improving early detection.
Shellenberger R; Nabhan M; Kakaraparthi S
Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192
[TBL] [Abstract][Full Text] [Related]
4. Observed and expected mortality in the German skin cancer screening pilot project SCREEN.
Eisemann N; Waldmann A; Holleczek B; Katalinic A
J Med Screen; 2018 Sep; 25(3):166-168. PubMed ID: 29169295
[TBL] [Abstract][Full Text] [Related]
5. Does skin cancer screening save lives? A detailed analysis of mortality time trends in Schleswig-Holstein and Germany.
Stang A; Jöckel KH
Cancer; 2016 Feb; 122(3):432-7. PubMed ID: 26480048
[TBL] [Abstract][Full Text] [Related]
6. Melanoma screening: Informing public health policy with quantitative modelling.
Gilmore S
PLoS One; 2017; 12(9):e0182349. PubMed ID: 28945758
[TBL] [Abstract][Full Text] [Related]
7. Systematic skin cancer screening in Northern Germany.
Breitbart EW; Waldmann A; Nolte S; Capellaro M; Greinert R; Volkmer B; Katalinic A
J Am Acad Dermatol; 2012 Feb; 66(2):201-11. PubMed ID: 22074699
[TBL] [Abstract][Full Text] [Related]
8. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000-2015).
Stang A; Jöckel KH; Heidinger O
Eur J Epidemiol; 2018 Mar; 33(3):303-312. PubMed ID: 29294207
[TBL] [Abstract][Full Text] [Related]
9. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996.
Schneider JS; Moore DH; Mendelsohn ML
J Am Acad Dermatol; 2008 May; 58(5):741-9. PubMed ID: 18068264
[TBL] [Abstract][Full Text] [Related]
10. The many unanswered questions related to the German skin cancer screening programme.
Stang A; Garbe C; Autier P; Jöckel KH
Eur J Cancer; 2016 Sep; 64():83-8. PubMed ID: 27371911
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
12. Thick melanoma in Tuscany.
Chiarugi A; Nardini P; Borgognoni L; Brandani P; Gerlini G; Rubegni P; Lamberti A; Salvini C; Lo Scocco G; Cecchi R; Sirna R; Lorenzi S; Gattai R; Battistini S; Crocetti E
G Ital Dermatol Venereol; 2019 Dec; 154(6):638-645. PubMed ID: 28290624
[TBL] [Abstract][Full Text] [Related]
13. [3-D imaging of skin cancers and survival].
Piérard GE
Rev Med Liege; 2009 Apr; 64(4):187-91. PubMed ID: 19514537
[TBL] [Abstract][Full Text] [Related]
14. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein].
Eisemann N; Waldmann A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Jan; 57(1):77-83. PubMed ID: 24357176
[TBL] [Abstract][Full Text] [Related]
15. Five-Year Outcomes of a Melanoma Screening Initiative in a Large Health Care System.
Matsumoto M; Wack S; Weinstock MA; Geller A; Wang H; Solano FX; Kirkwood JM; Ferris LK
JAMA Dermatol; 2022 May; 158(5):504-512. PubMed ID: 35385051
[TBL] [Abstract][Full Text] [Related]
16. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003.
Downing A; Newton-Bishop JA; Forman D
Br J Cancer; 2006 Jul; 95(1):91-5. PubMed ID: 16755289
[TBL] [Abstract][Full Text] [Related]
17. Reducing mortality in individuals at high risk for advanced melanoma through education and screening.
Geller AC; Swetter SM; Oliveria S; Dusza S; Halpern AC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S87-94. PubMed ID: 22018072
[TBL] [Abstract][Full Text] [Related]
18. Melanoma death prevention: moving away from the sun.
Mitchell JK; Leslie KS
J Am Acad Dermatol; 2013 Jun; 68(6):e169-75. PubMed ID: 23545369
[TBL] [Abstract][Full Text] [Related]
19. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.
Hübner J; Waldmann A; Geller AC; Weinstock MA; Eisemann N; Noftz M; Bertram S; Nolte S; Volkmer B; Greinert R; Breitbart E; Katalinic A
Br J Cancer; 2017 Jan; 116(2):253-259. PubMed ID: 27898656
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
